0.0001USD0.00%Mkt Cap: 23236 USDP/E: —Last update: 2026-05-29
Ocean Biomedical, Inc., a biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States. The company's oncology product candidat…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap23.24K USD
Enterprise Value—
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-9.48M USD
Revenue/Share—
Last Price0.0001 USD
Fiscal Year EndDec 2024
MR QuarterMar 2025
Employees7
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.00
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.00
EPS (TTM)-0.91
EPS (Forward)-0.89
52W Range
0.00001% of range0.0150
52W High0.0150 USD
52W Low0.0000 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE9.71%
ROA-1051.00%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-4.18M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-23001.48%
Net Debt—
Net Debt/EBITDA—
Balance Sheet
Debt/Equity-0.17
Current Ratio0.06
Quick Ratio—
Book Value/Sh-0.5570 USD
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.232.37M
Float208.41M
Insiders10.31%
Institutions0.00%
Short Interest
Short Ratio0.1d
Short % Float2.05%
Short % Out.1.77%
Shares Short2.93M
Short (prev mo.)5.72M
Technical
SMA 500.0004 (-71.6%)
SMA 2000.0019 (-94.8%)
Beta-0.07
S&P 52W Chg27.94%
Avg Vol (30d)64.07K
Avg Vol (10d)41.09K
Technical Indicators
RSI (14)41.7
MACD-0.0000
MACD Signal-0.0000
MACD Hist.-0.0000
BB Upper0.0004 USD
BB Middle0.0003 USD
BB Lower0.0001 USD
BB Width129.50%
ATR (14)0.0002 USD
Vol Ratio (20d)0.22x